| Comment Number: | 522418-07142 |
| Received: | 7/9/2006 4:15:17 PM |
| Organization: | Natures Sunshine Products |
| Commenter: | Regina Leitz |
| State: | LA |
| Subject: | Business Opportunity Rule |
| Title: | Notice of Proposed Rulemaking |
| CFR Citation: | 16 CFR Part 437 |
| No Attachments |
Comments:
Dear Sir or Madam, I am writing due to the concerned proposal of the FTC's Business Oppurtunity Rule R511993 if adopted in its present form would have a large impact on my livelihood as a NSP distributor. All policies currently in place by Natures Sunshine demonstrates that it is highly qualified in policing itself to comply with industry regulations and goes above and beyond the limits in handling complaints, complies with buy back requirements when applicable, and it makes it easy to exit the company if one should find the oppurtunity not right for them. I find the 7 day waiting period excessive and extreme. One is not requried to abide by the same rules when purchasing medication from a pharmacy, nor does the pharmacy have to disclose current lawsuits involving medications they currently distribute ( ex. Vioxx etc...) The idea of giving references of the 10 nearest distributors is impractical. Clientel usually is built through trust and service as in any other industry and we are unfairly being targeted. I have bought and recommended and sold NSP for 4 years now. I regard the product not only to be the best in the industry but it is made using the highest of standards. Even though I have not devoted myself full time to selling the Natures Sunshine Products, I and my family have enjoyed the benefits of the extra income earned on sales. I am confident in the product line as well as the company and enjoy working for one that has such a good reputation. Please rethink regulating a business that is already a self-regulator with high standards. Sincerely, Regina Leitz